MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
MIRA — MIRA Pharmaceuticals, Inc. Common Stock
NasdaqMIRA Pharmaceuticals, Inc. Common Stock
$0.71
-0.02(-3.22%)
- O
- 0.76
- H
- 0.76
- L
- 0.70
- V
- 103.67K
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About MIRA
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateAug 3, 2023
Employees2
Stock ExchangeNasdaq
Ticker SymbolMIRA
Key Financial Statistics
| Market Cap | $30.68M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.60 - $2.45 |
| 52-Week Avg Volume | 969.3K |
| VWAP | $0.73 |
| Transactions | 565 |
| Total Recorded Bars | 797 days |